|

Virtual cell

Artistic depiction of red blood cells on a white background, emphasizing medical concepts.

Hani Goodrazi – Arc institute has been working on virtual cell.

Drugs fail due to overfit experimental models, You need screen drugs with better models of human biology.

Geneva is platfrom that brings tumor models into perturbation model – that is a transcriptomics assay that deconvolves into effect. Take multiple cell line and then treat with 2 drugs and can distinguish the cell lines that is very sensitive to one drug. This can be done with Patient xenografts. In vitro and in vivo programs are different. GENEVA platform paper – Nature cancer paper.

Can drug screening be moved into these complex models? But it is still a model and not human. This will not take you all the way to a human drug.

G12C tumors when treated with Sotorasib (a covalent binding drug) – even with this drug it shows a lot of heterogeneity in response. We can collect data from the patient but cannot run a test on the patient.

Virtual cell – in silico tumor models. One concept many manifestations. It is a framework not a singluar model. The bar is xenograft model that is used for drug discovery.

A virtual cell need to generalize beyond training universe. Gene regulatory network is complex but not infinite so it is in bounded complexity.

Lessons from alpha-fold:

GENEVA extended. Cell Bxio ties cellural function to cellular state. In DNA there is no structure to functional relationship for example. A cell state is a lower projection of multiomic measurement – UMAS. In cells in various states – abstractions of gene regulatory modules. Evolution is doing pertubration management.

Perturbation proves causation.

Tahoe company from GENEVA created multiple datasets. They have created datasets with different cells and drugs. They can show Kras G12C as an important determinant and can predict mechanism of action. Arc virtual cell atlas – exists in Github.

Perturbation problem – start with a population of cells and then figure out how they affect the cell state. STATE directly models the perturbation process. – generative process. Population of cells are modeled and should be the same, and they are covariate adjusted and they move into a new state.

ST – is a generalization of common approaches – Cell is integrating information from the neighbor.

Evaluated perturbation prediction models. Pearson correlation from Tahoe 100M, Parse-PMC, Plogle-Nadig and also from Differentially expressed genes.

STATE has improved over existing baselines.

Arc institute also has a virtual cell challenge. It is data limited and not compute limited.

Arc also has DNA data set which is compute limited.

Similar Posts

  • |

    Reinforcement learning

    Reinforcement learning is a method that drives learning and memory in primitive species such as birds, humans and other living species to its use in machine learning. It is used to influence the behavior of us humans on social media to its use to train machines. The essential components were initiated by BF Skinner 20th…

  • |

    ALS and TDP43

    Almost 90% of ALS is thought to be sporadic. The reasons are not well understood and thought to be oxidative stress, damaged endoplasmic reticulum, mitochondria, cytoskeleton or misregulation of RNA pathways. One protein implicated is TDP43 which sits as a junction of ALS pathogenic path by binding to RNA modulation synthesis, splicing, stability and transport….

  • | |

    Personalized health

    There are many companies that offer personalized health solutions to help individuals. Some offer imaging services while others are more specific: for cancer diagnosis or hormone levels. Consider some examples: Personalis: Cancer Biomarker Discovery through liquid biopsy and other precision oncology tools. They have collaborations with many institutions but it is not clear what makes…

  • Risk and Uncertainity

    There’s a difference between risk and uncertainty. Let’s think about biology. If we compare humans, each of us has two eyes, two hands, and two legs, and we’re mostly similar genetically. Therefore, when we develop a medication, there’s a certain risk in what effects and side-effects it will have. This is a risk. It’s quantifiable;…